1094TiP A randomized, controlled, open-label, phase II study of cemiplimab as a single agent and in combination with RP1 in patients with advanced cutaneous squamous cell carcinoma [CERPASS]

2021 ◽  
Vol 32 ◽  
pp. S904
Author(s):  
A.M. Haydon ◽  
M. Alamgeer ◽  
D. Brungs ◽  
F. Collichio ◽  
N.I. Khushalani ◽  
...  
2014 ◽  
Vol 25 (10) ◽  
pp. 2047-2052 ◽  
Author(s):  
M.C. Foote ◽  
M. McGrath ◽  
A. Guminski ◽  
B.G.M. Hughes ◽  
J. Meakin ◽  
...  

2021 ◽  
Vol 32 ◽  
pp. S885
Author(s):  
R. Ramella Munhoz ◽  
V.P. de Camargo ◽  
G. Nader Marta ◽  
M.M. Queiroz ◽  
J. Cury-Martins ◽  
...  

2020 ◽  
Vol 21 (2) ◽  
pp. 294-305 ◽  
Author(s):  
Michael R Migden ◽  
Nikhil I Khushalani ◽  
Anne Lynn S Chang ◽  
Karl D Lewis ◽  
Chrysalyne D Schmults ◽  
...  

2000 ◽  
Vol 11 (2) ◽  
pp. 239-241 ◽  
Author(s):  
S.J. Clarke ◽  
J. Zalcberg ◽  
I. Olver ◽  
P.L.R. Mitchell ◽  
D. Rischin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document